Therapy of essential hyperlipidemias
Schlierf, G.; Kahlke, W.
Minerva Medica 63(14): 853-855
1972
ISSN/ISBN: 0026-4806 PMID: 5012560 Document Number: 55087
Document emailed within 1 workday
Related Documents
Wolfram, G. 1981: Drug therapy of hyperlipidemias Wiener Medizinische Wochenschrift 131(13-14): 333-338Cox, R.A. 2003: The hyperlipidemias Boletin de la Asociacion Medica de Puerto Rico 95(5): 36-44
Assmann, G.; Schriewer, H. 1980: The diagnosis of hyperlipidemias Therapeutische Umschau. Revue Therapeutique 37(11): 965-972
Hidalgo Vicario, M.I. 1991: Diagnosis of hyperlipidemias Anales Espanoles de Pediatria 35 Suppl 45(4): 12-16
Feder, D.; Langer, A.L.; Alexandrino, E.; Medeiros, S.; Lotto, M.; Valente, O. 1986: Probucol in the treatment of hyperlipidemias Arquivos Brasileiros de Cardiologia 46(2): 77-80
Mori, S.; Ito, H. 2007: Classification of hyperlipidemias in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 237-240
Lugo-Somolinos, A.íd.; Sánchez, J.E. 2003: Xanthomas: a marker for hyperlipidemias Boletin de la Asociacion Medica de Puerto Rico 95(4): 12-16
Assmann, G. 1979: Current diagnosis of hyperlipidemias Der Internist 20(11): 559-564
Berg, K. 1982: The genetics of the hyperlipidemias and coronary artery disease Progress in Clinical and Biological Research 103 Pt B: 111-125
Schoonmaker, F.W.; King, S.B.; Vijay, N.K. 1973: Hyperlipidemias in predicting coronary artherosclerosis by arteriography Rocky Mountain Medical Journal 70(8): 32-36
Szczeklik, A. 1974: Differential diagnosis of hyperlipidemias and hypolipidemias in endocrinologic diseases Przeglad Lekarski 31(0): Suppl:79-82
Lipovetskiĭ, B.M. 1993: Genealogy and the clinical manifestations of familial hyperlipidemias types IIa and IIb Terapevticheskii Arkhiv 65(12): 34-38
Buxtorf, J.C.; Delplanque, B.; Baudet, M.F.; Beaumont, J.L. 1979: Lipid particles agglutinated in hyperlipidemias with opalescent sera La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(3-4): 193-197
Widhalm, K. 1985: Effect of diet on serum lipoproteins in children with various forms of hyperlipidemias Progress in Clinical and Biological Research 188: 145-159
Rahn, K.H. 1972: Therapy of essential hypertension Hippokrates 43(1): 31-44
Meoni, S.; Costa, S.; Rossi, R. 1971: A drug for therapy of essential hypertension Minerva Medica 62(30): 1581-1587
Lund-Johansen, P. 1972: Diuretics in the therapy of essential hypertension Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(5): 336-338
Gugliotta, L.; Catani, L.; Vianelli, N.; Mattioli Belmonte, M.; Cascione, M.L.; Bendani, M.; Fanin, R.; Michieli, M.G.; Baccarani, M.; Tura, S. 1991: Essential thrombocythemia: therapy with alpha interferons Haematologica 76(Suppl 3): 374-377
Winterfeld, H.J.; Siewert, H.; Strangfeld, D. 1995: Experiences with running therapy in essential hypertension Praxis 84(12): 341-348
Belova, L.A.; Ogloblina, O.G.; Tvorogova, M.G. 1996: A method to eliminate lipids from blood plasma in hyperlipidemias to measure activities of proteinases and their inhibitors Klinicheskaia Laboratornaia Diagnostika 3: 50-51